Catalyst Wire Dossier Catalyst Wire Dossier

Generic Imiquimod Cream 3.75%

imiquimod cream 3.75% · Actavis Mid-Atlantic LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Generic Imiquimod Cream 3.75%, covering 2011-12-30 to 2011-12-30. Get the full timeline:

Most recent: Clinical Trial Update: A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses [NA]

See pricing